Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma

av Chmielowski, Bartosz
Publicerad 2013

Presentation of antagonist peptides to naive CD4(+) T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cells

av Chmielowski, Bartosz, Pacholczyk, Rafal, Kraj, Piotr, Kisielow, Pawel, Ignatowicz, Leszek
Publicerad 2002

The specific T-cell response to antigenic peptides is influenced by bystander peptides

av Nowak, Izabela, Pajtasz-Piasecka, Elżbieta, Chmielowski, Bartosz, Ignatowicz, Leszek, Kuśnierczyk, Piotr
I publikationen Cell Mol Biol Lett (2006)

Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review

av Copley-Merriman, Catherine, Stevinson, Kendall, Liu, Frank Xiaoqing, Wang, Jingshu, Mauskopf, Josephine, Zimovetz, Evelina A., Chmielowski, Bartosz
I publikationen Medicine (Baltimore) (2018)

A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-s...

av Urba, Walter, Chmielowski, Bartosz, Loo, Deryk, Baughman, Jan, Chen, Francine, Moore, Paul, Bonvini, Ezio, Vasselli, James, Wigginton, Jon, Rizvi, Naiyer
I publikationen J Immunother Cancer (2015)

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

av Kudchadkar, Ragini, Ernst, Scott, Chmielowski, Bartosz, Redman, Bruce G, Steinberg, Joyce, Keating, Anne, Jie, Fei, Chen, Caroline, Gonzalez, Rene, Weber, Jeffrey
I publikationen Cancer Med (2015)

Endocrinopathies with Use of Cancer Immunotherapies

av Villa, Natalie M., Farahmand, Abtin, Du, Lin, Yeh, Michael W., Smooke-Praw, Stephanie, Ribas, Antoni, Chmielowski, Bartosz, Cherry, Grace, Leung, Angela M.
I publikationen Clin Endocrinol (Oxf) (2017)

The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes Across a Wide Range of Concentrations

av Comin-Anduix, Begoña, Chodon, Thinle, Sazegar, Hooman, Matsunaga, Douglas, Mock, Stephen, Jalil, Jason, Escuin-Ordinas, Helena, Chmielowski, Bartosz, Koya, Richard C., Ribas, Antoni
Publicerad 2010

Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma

av Mehta, Niraj, Selch, Michael, Wang, Pin-Chieh, Federman, Noah, Lee, Jay M., Eilber, Fritz C., Chmielowski, Bartosz, Agazaryan, Nzhde, Steinberg, Michael, Lee, Percy
Publicerad 2013

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

av Zuckerman, Jonathan E., Gritli, Ismael, Tolcher, Anthony, Heidel, Jeremy D., Lim, Dean, Morgan, Robert, Chmielowski, Bartosz, Ribas, Antoni, Davis, Mark E., Yen, Yun
Publicerad 2014

CRAF R391W is a melanoma driver oncogene

av Atefi, Mohammad, Titz, Bjoern, Tsoi, Jennifer, Avramis, Earl, Le, Allison, Ng, Charles, Lomova, Anastasia, Lassen, Amanda, Friedman, Michael, Chmielowski, Bartosz, Ribas, Antoni, Graeber, Thomas G.
I publikationen Sci Rep (2016)

Infiltration of CD8 T cells and expression of PD-1 and PD-L1 in synovial sarcoma

av Nowicki, Theodore S., Akiyama, Ryan, Huang, Rong Rong, Shintaku, I. Peter, Wang, Xiaoyan, Tumeh, Paul C., Singh, Arun, Chmielowski, Bartosz, Denny, Christopher, Federman, Noah, Ribas, Antoni
I publikationen Cancer Immunol Res (2016)

Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes

av Shurell, Elizabeth, Singh, Arun S., Crompton, Joseph G., Jensen, Sarah, Li, Yunfeng, Dry, Sarah, Nelson, Scott, Chmielowski, Bartosz, Bernthal, Nicholas, Federman, Noah, Tumeh, Paul, Eilber, Fritz C.
I publikationen Oncotarget (2016)

Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma

av Comin-Anduix, Begoña, Sazegar, Hooman, Chodon, Thinle, Matsunaga, Douglas, Jalil, Jason, von Euw, Erika, Escuin-Ordinas, Helena, Balderas, Robert, Chmielowski, Bartosz, Gomez-Navarro, Jesus, Koya, Richard C., Ribas, Antoni
Publicerad 2010

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway

av Atefi, Mohammad, von Euw, Erika, Attar, Narsis, Ng, Charles, Chu, Connie, Guo, Deliang, Nazarian, Ramin, Chmielowski, Bartosz, Glaspy, John A., Comin-Anduix, Begonya, Mischel, Paul S., Lo, Roger S., Ribas, Antoni
Publicerad 2011

Long term Survival with CTLA-4 blockade Using Tremelimumab

av Eroglu, Zeynep, Kim, Dae Won, Wang, Xiaoyan, Camacho, Luis H., Chmielowski, Bartosz, Seja, Elizabeth, Villanueva, Arturo, Ruchalski, Kathleen, Glaspy, John A., Kim, Kevin B., Hwu, Wen-Jen, Ribas, Antoni
I publikationen Eur J Cancer (2015)

Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model

av Kawaguchi, Kei, Murakami, Takashi, Chmielowski, Bartosz, Igarashi, Kentaro, Kiyuna, Tasuku, Unno, Michiaki, Nelson, Scott D., Russell, Tara A., Dry, Sarah M., Li, Yunfeng, Eilber, Fritz C., Hoffman, Robert M.
I publikationen Oncotarget (2016)

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

av Larkin, James, Chmielowski, Bartosz, Lao, Christopher D., Hodi, F. Stephen, Sharfman, William, Weber, Jeffrey, Suijkerbuijk, Karijn P. M., Azevedo, Sergio, Li, Hewei, Reshef, Daniel, Avila, Alexandre, Reardon, David A.
I publikationen Oncologist (2017)

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial

av D’Angelo, Sandra P., Russell, Jeffery, Lebbé, Céleste, Chmielowski, Bartosz, Gambichler, Thilo, Grob, Jean-Jacques, Kiecker, Felix, Rabinowits, Guilherme, Terheyden, Patrick, Zwiener, Isabella, Bajars, Marcis, Hennessy, Meliessa, Kaufman, Howard L.
I publikationen JAMA Oncol (2018)

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

av Nowicki, Theodore S., Escuin-Ordinas, Helena, Avramis, Earl, Chmielowski, Bartosz, Chodon, Thinle, Berent-Maoz, Beata, Wang, Xiaoyan, Kaplan-Lefko, Paula, Yang, Lili, Baltimore, David, Economou, James S., Ribas, Antoni, Comin-Anduix, Begoña
I publikationen J Immunother (2018)